ABSTRACT. We investigated the association between CASP-9 polymorphisms and susceptibility to neoplasm. Fourteen studies with a total of 2733 neoplasm cases and 3352 healthy controls were included. Meta-analysis showed that the rs4645981*T allele and the rs4645981*T allele carrier were positively associated with neoplasm susceptibility [odds ratio (OR) = 1.43, 95% confidence interval (95%CI) = 1.12-1.81, P = 0.004; OR = 1.46, 95%CI = 1.10-1.93, P = 0.009, respectively]. However, the rs1052576*A allele, rs1052576*A carrier, rs2308941*T allele, and rs2308941*T carrier might decrease the risk of cancer (OR = 0.72, 95%CI = 0.58-0.89, P = 0.003; OR = 0.76, 95%CI = 0.63-0.92, P = 0.004; OR = 0.20, 95%CI = 0.09-0.45, P < 0.0001; OR = 0.21, 95%CI = 0.06-0.75, P = 0.02, respectively). There was no significant association between rs1263, rs1052571, rs2308950, rs4645978, rs4645980, rs4645982, and rs4646018 and cancer risk (all P > 0.05). In conclusion, this meta-analysis suggests that CASP-9 gene polymorphisms are involved in the pathogenesis of various cancers. The rs4645981*T allele and the rs4645981*T allele carrier might increase the risk of cancer, but the rs1052576*A allele, rs1052576*A carrier, rs2308941*T allele, and rs2308941*T carrier might be protective.
INTRODUCTION
Caspase-9 is a cysteine protease encoded by the CASP-9 gene (Thornberry, 1997; Shiozaki et al., 2003) located on chromosome 1p36.1 (Bian et al., 2004) . A member of the caspase gene family, caspase-9, plays an important role in the mitochondrial death pathway. In this pathway, cell death signals lead to mitochondrial release of cytochrome c, which binds and facilitates formation of the heptameric apoptosome that recruits and activates caspase-9. During apoptosis, the extrinsic and intrinsic pathways in humans use the caspase enzyme cascade; the extrinsic pathway utilizes caspase-8 and -10, while the intrinsic pathway employs caspase-9 (Kesarwani et al., 2011) . Complex recruitment of caspase-9 leads to activation through formation of the apoptosome (Gil et al., 2002) . Many studies have identified significant associations between the caspase gene cluster and cancer susceptibility, particularly for CASP-7, -8, and -10 (Oliveira et al., 2004; De Vecchi et al., 2009; Liu et al., 2010) . However, Catchpoole and Lock (2001) found that CASP-9 is also strongly associated with neuroblastoma. Liamarkopoulos et al. (2011) confirmed that CASP-9 genetic polymorphisms influence the risk of gastric cancer. Moreover, Choi et al. (2012) demonstrated CASP-9 involvement in the pathogenesis of lung cancer. Seo et al. (2011) suggested that ovarian cancer susceptibility is correlated with CASP-9. However, these studies did not characterize the precise relationship between CASP-9 and cancer risk, and uncertainty remains. We performed this study to describe the overall associations between CASP-9 and cancer risk.
MATERIAL AND METHODS

Literature search
PubMed, Cochrane library, Embase, Web of Science, Springerlink, CNKI, and CBM databases were searched (last search was updated on May 10, 2012) extensively to identify relevant studies. The search terms included ["Caspase-9" or "ICE-Like Apoptotic Protease 6" or "Procaspase-9" or "Caspase 9" (Mesh)] and ["SNPs" or "SNP" or "polymorphism, genetic" (Mesh)] and ["cancer" or "tumor" or "Neoplasms" (Mesh) ]. References in eligible studies or textbooks were also reviewed.
Inclusion and exclusion criteria
The studies included had to meet the following criteria: case-control study; focused on associations between CASP-9 polymorphisms and cancer susceptibility; all patients with the diagnosis of cancer confirmed by pathological examination of surgical specimens; the frequencies of alleles or genotypes in case and control groups could be determined; and the publication was in English or Chinese. Studies were excluded when they were not case-control studies about CASP-9 gene polymorphisms and cancer susceptibility; if they were based on incomplete data; or if useless or overlapping data were reported.
Data extraction
Using a standardized form, data from the studies published were extracted indepen-dently by 2 reviewers (Z.Y.Z. and Y.X.). The following information was extracted from each article: first author, year of publication, country, language, ethnicity, study design, diagnostic criteria, source of cases and controls, number of cases and controls, mean age, sample, pathological types, detection methods, polymorphism genotype frequency, and evidence of HardyWeinberg equilibrium (HWE) in controls. In case of conflicting evaluations, an agreement was reached following discussion with a third reviewer (R.W.).
Quality assessment
Two reviewers (X.Y.J. and X.T.) independently assessed the quality of the papers according to modified STROBE quality score systems (Son et al., 2006; Zhang et al., 2011) . Forty quality appraisal assessment items were used in this meta-analysis, with scores ranging from 0 to 40. Scores of 0-20, 20-30, and 30-40 were defined as low, moderate, and high quality, respectively. Disagreement was resolved by discussion with a third reviewer (R.W.).
Statistical analysis
Allele or genotype frequencies of CASP-9 SNPs were determined by allele counting. The odds ratio (OR) and 95% confidence interval (95%CI) were calculated using Review Manager version 5.1.6 (provided by the Cochrane Collaboration, available at: http://ims. cochrane.org/revman/download) and STATA version 12.0 (Stata Corp., College Station, TX, USA). Between-study variation and heterogeneity were estimated using the Cochrane Q-test (Higgins and Thompson, 2002; Zintzaras and Ioannidis, 2005 ) (P ≤ 0.05 indicated statistically significant heterogeneity). We also quantified the effect of heterogeneity by using the I 2 test. I 2 ranges between 0 and 100% and represents the proportion of inter-study variability that can be attributed to heterogeneity rather than chance. I 2 values of 25, 50, and 75% were defined as low, moderate, and high estimates, respectively. When a significant Q-test (P < 0.10) or I 2 > 50% indicated heterogeneity across studies, the random-effect model was used for metaanalysis, or the fixed-effect model was used. To establish the effect of heterogeneity on the meta-analysis conclusions, subgroup analysis was performed. We determined whether the genotype frequencies of the controls were in HWE using the χ 2 test. Subgroup analysis based on nationality was used to explore and explain diversity among the results of different studies. Sensitivity analysis was performed by sequential omission of individual studies. Publication bias was investigated by Begger's funnel plot, and funnel plot asymmetry was assessed by the Egger linear regression test (Peters et al., 2006) ; statistical significance was indicated by the Egger test (P < 0.05). All P values were two-sided. To ensure reliability and accuracy, two reviewers (Z.Y.Z. and Y.X.) independently populated the data in the statistical software programs and obtained the same results.
RESULTS
Characteristics of the studies included
Fourteen studies (Park et al., 2006; Fang et al., 2007; Lan et al., 2007; Lou et al., 2007; He et al., 2008; Hosgood et al., 2008; Ye et al., 2008; Gangwar et al., 2009; Ulybina et al., 2009; Wu, 2009; Kesarwani et al., 2011; Ni et al., 2011; Theodoropoulos et al., 2010 Theodoropoulos et al., , 2011 were included and 80 were excluded, based on the inclusion and exclusion criteria. A flow chart representing study selection is shown in Figure 1 . The total numbers of cancer cases and healthy controls were 2733 and 3352 in 14 case-control studies, which evaluated the relationship between CASP-9 gene polymorphisms and susceptibility to cancer. Publication year ranged from 2005 to 2011. All patients fulfilled the diagnosis criteria of malignant neoplasm confirmed by pathological examination of the surgical specimen. The source of controls was based on a healthy population. Ten SNPs in CASP-9 were addressed, including rs1263, rs1052571, rs1052576, rs2308941, rs2308950, rs4645978, rs4645980, rs4645981, rs4645982, and rs4646018. HWE tests were performed on the genotype distribution of controls in all the studies included. We found that 4 studies mainly from Asian populations were in non-HWE (P < 0.05), while all others were in HWE (P > 0.05). All quality scores were >20 (moderate to high quality). The characteristics and methodological quality of the studies included are summarized in Table 1 .
Association between CASP-9 gene polymorphisms and cancer risk
A summary of the meta-analysis of the association between CASP-9 gene polymorphisms and cancer susceptibility is provided in Table 2 . The meta-analysis showed that rs4645981, including the rs4645981*T allele and the rs4645981*T allele carrier, was positively associated with cancer susceptibility (OR = 1.43, 95%CI = 1.12-1.81, P = 0.004; OR = 1.46, 95%CI = 1.10-1.93, P = 0.009, respectively). However, there were negative associations between rs1052576, rs2308941, and cancer susceptibility. The rs1052576*A allele, rs1052576*A carrier, rs2308941*T allele, and rs2308941*T carrier might decrease the risk of cancer (OR = 0.72, 95%CI = 0.58-0.89, P = 0.003; OR = 0.76, 95%CI = 0.63-0.92, P = 0.004; OR = 0.20, 95%CI = 0.09-0.45, P < 0.0001; OR = 0.21, 95%CI = 0.06-0.75, P = 0.02, respectively). In addition, there were no significant associations for rs1263, rs1052571, rs2308950, rs4645978, rs4645980, rs4645982, and rs4646018 (all P > 0.05). The significance of pooled OR in all individual and subgroup analyses was not excessively influenced by omitting any single study or the non-HWE studies. The positive associations between CASP-9 gene polymorphisms and cancer susceptibility are shown in Figure 2 . Table 2 . Meta-analysis of the association between CASP-9 gene polymorphisms and cancer risk. OR = odds ratio; 95%CI = 95% confidence interval. 
Publication bias
Publication bias of the literatures was accessed by Begger's funnel plot and the Egger linear regression test. The Egger linear regression test was used to measure the asymmetry of the funnel plot. All graphical funnel plots appeared to be symmetrical (Figure 3) . The Egger test also showed no statistically significant publication bias (all P > 0.05). Findings of the Egger publication bias test are shown in Table 3 . Begger's funnel plot of publication bias for the association between rs1052576, rs4645978, rs4645982, and susceptibility to lung cancer. 
DISCUSSION
Caspase-9 may cause aberrant apoptosis inhibition, and the relevance of this process has been demonstrated in a number of cancer types (Kelly et al., 2010) . Caspase-9 is a member of the Caspase family of cysteine proteases that have been implicated in apoptosis and cytokine processing (Bian et al., 2004) . As a central initiator caspase, caspase-9 can be triggered in a response to stimuli that damage mitochondria directly or by signals originating in other parts of the cell (Potokar et al., 2003) . Although many studies have evaluated the association between CASP-9 gene polymorphisms and cancer risk, the results remain controversial.
In this meta-analysis, we examined 10 SNPs in the CASP-9 gene, including rs1263, rs1052571, rs1052576, rs2308941, rs2308950, rs4645978, rs4645980, rs4645981, rs4645982, and rs4646018. Our study showed that the rs4645981*T allele and the rs4645981*T allele carrier had significant associations with cancer risk after adjustment for multiple testing. However, the rs1052576*A allele, rs1052576*A carrier, rs2308941*T allele, and rs2308941*T carrier might decrease the risk of cancer. There was no association between rs1263, rs1052571, rs2308950, rs4645978, rs4645980, rs4645982, and rs4646018 and cancer risk (all P > 0.05). Although a recent collaborative study found an association for other SNPs of the CASP-9 gene and their haplotypes, there has been no pooled analysis of rs1263, rs1052571, rs2308950, rs4645978, rs4645980, rs4645982, and rs4646018 and cancer risk. Some studies have shown that ethnicity may influence cancer susceptibility through variations in genetic background and environmental exposure leading to various gene-gene and gene-environmental interactions. Sensitivity analysis was performed by omitting any single study and non-HWE studies; no influence was found.
The many limitations of our meta-analysis should be addressed. First, the relevant research articles are few and the sample size of this meta-analysis was not large. In addition, some relevant studies could not be included in our analysis due to incomplete raw data. Third, we were not able to address the sources of heterogeneity in all studies. Fourth, although all cases and controls were well defined with similar inclusion criteria, there may be factors not taken into account that may have influenced our results. Most important, our meta-analysis was based on unadjusted OR estimates because not all publications presented adjusted OR; when they did, the OR were not adjusted by the same potential confounders, such as ethnicity, gender, geographic distribution, etc. Given these results, additional investigation in these areas is needed, and our conclusions should be interpreted cautiously.
In conclusion, this meta-analysis of 14 case-control studies demonstrated that CASP-9 gene polymorphisms are involved in the pathogenesis of various cancer. The rs4645981*T allele and the rs4645981*T allele carrier might increase the risk of cancer, but the rs1052576*A allele, rs1052576*A carrier, rs2308941*T allele, and rs2308941*T carrier might be protective. As few studies are available in this field and evidence remains limited, we emphasize the necessity to conduct large studies with adequate methodological quality and proper control of confounding factors in order to obtain valid results.
